Skip to main content
SKINBIOTHERAPEUTICS PLC logo

SKINBIOTHERAPEUTICS PLC — Investor Relations & Filings

Ticker · SBTX ISIN · GB00BF33H870 LEI · 213800YMQOCB23FX6I06 IL Manufacturing
Open in API
Filings indexed 314 across all filing types
Latest filing 2025-11-26 Major Shareholding Noti…
Country GB United Kingdom
Listing IL SBTX

About SKINBIOTHERAPEUTICS PLC

https://www.skinbiotherapeutics.com/

SkinBioTherapeutics PLC is a life science company focused on advancing skin health by harnessing the human microbiome. Its proprietary SkinBiotix® platform technology utilizes probiotic lysates to protect, manage, and restore skin. The company develops and commercializes products across several healthcare sectors, including cosmetics, food supplements, medical devices, and pharmaceuticals. Key offerings include AxisBiotix, a probiotic food supplement designed to address psoriasis symptoms, and the Dermatonics line of specialized foot care products. Through its acquisition of Bio-Tech Solutions, the company also provides formulation, manufacturing, and packaging services for healthcare, personal care, and hygiene products.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This is a classic 'Major Shareholding Notification' filing, which corresponds to the MRQ category.
2025-11-26 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their interest in a company crosses specific voting rights thresholds. This fits the definition of a 'Major Shareholding Notification' (MRQ).
2025-11-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. It explicitly details a change in share ownership (11.206% voting rights) by a major shareholder (Mark H Dixon) in SkinBioTherapeutics plc. This type of regulatory disclosure regarding significant shareholding thresholds is classified as a Major Shareholding Notification (MRQ).
2025-11-04 English
Directorate Change
Board/Management Information Classification · 100% confidence The document is an official announcement from SkinBioTherapeutics plc regarding a 'Directorate Change', specifically the departure of an Executive Director and Chief Operating Officer. This falls directly under the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-10-14 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is a regulatory requirement for disclosing changes in significant share ownership (crossing thresholds). This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-10-13 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement in the UK for shareholders to notify the issuer and the FCA when their voting rights cross certain thresholds. This fits the definition of a 'Major Shareholding Notification' (MRQ).
2025-10-13 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.